Services
Transforming Pharmaceutical Innovation Through AI-Driven Drug Discovery and Chemistry Solutions
We are an AI-powered company delivering fully integrated, end-to-end solutions across industries, accelerating innovation from discovery to delivery to improve health outcomes globally.
These are the industries we primarily serve
AI-Powered Drug Discovery
Turning Ideas into Life-Changing Therapies
Powered by Generative AI, Predictive AI, and Physics-Based Models
Our unique platform offers revolutionary capabilities that accelerate and excel in drug discovery and development:
- Cutting-edge NCE AI models to generate and optimize a wide range of molecules
- Advanced Molecular Dynamics and Quantum Chemistry for optimal selection
- Comprehensive in silico analysis of 100+ properties and metrics
- Precise in-silico differentiation between high and low potency activities, optimizing drug discovery outcomes
Core Capabilities
- Druggable target discovery
- Crystal structure prediction
- Pocket identification and analysis
- Advanced binding site characterization
- In-silico molecular design and optimization
- Hit-to-lead optimization programs
- Advanced Molecular Dynamics simulations
- Comprehensive property prediction
- Ligand-centric approaches
- Target-centric methodologies
- Advanced computational screening
- Rapid identification of new therapeutic applications
- Novel E3 ligase discovery
- Molecular glue design
- Ternary complex stability evaluation
- In-silico degradation efficiency prediction
- Antibody-drug conjugate payload design
- Linker optimization for targeted delivery
- Stability and cleavage profile prediction
- Peptide engineering for conjugation
Proprietary Technologies
- PROTAC-Design-Evaluator (PRODE): Advanced method for in-silico PROTAC design
- Molecular Glue-Design-Evaluator (MOLDE): Cutting-edge molecular glue design platform
- Physics-based quantum chemistry models ensuring high reaction feasibility
- Generative AI for novel molecule generation and optimization
Unlike others in the field, Sravathi AI offers a complete suite of capabilities — from AI drug discovery and quantum chemistry to yield optimization and impurity prediction. While competitors cover only parts of the pipeline, we deliver end-to-end solutions to accelerate and streamline drug development.
Chemistry AI
Revolutionizing Chemical Process Development
Rule-Based + Data-Driven AI Platform Transforming Chemistry Through Process Intensification
Our Chemistry AI Platform combines artificial intelligence with advanced process intensification technologies to deliver:
- High automation with exceptional accuracy
- Quantum Chemistry integration ensuring high reaction feasibility
- Diverse route ideas with optimal feasibility
- Cost reduction of R&D expenses by over 70%
Core Capabilities
- AI-powered synthesis route design
- Commercially available raw material optimization
- Shortest synthesis path identification
- Non-infringing route development for patent extension
- Comprehensive impurity identification
- Unknown impurity formation prediction
- Toxicophore prediction and AMES mutagenicity assessment
- Extractable and leachable compound prediction
- Optimal reaction condition identification
- Best catalyst, solvent, and reagent selection
- Temperature and time optimization
- Automated condition screening
- Advanced separation methodology design
- Solvent extraction optimization
- Recrystallization process development
- High purity (99.5%+) and recovery rate (90%+) achievement
- Packaging material interaction analysis
- Process-induced contamination prediction
- Regulatory compliance assessment
- Toxicity profiling
- Migration risk evaluation
Technology Integration
Sravathi AI uniquely integrates two powerful platforms
AI Technology
- Advanced artificial intelligence algorithms
- Machine learning models for molecular design
- Predictive analytics for drug discovery
Process Intensification
- Flow chemistry expertise
- Microreactor technology
- Continuous manufacturing solutions